References
1. Styne DM, Arslanian SA, Connor EL, et al. Pediatric obesity-assessment, treatment, and prevention: An endocrine society clinical practice guideline. J Clin Endocrinol Metab . 2017. doi:10.1210/jc.2016-2573
2. Hruby A, Manson JAE, Qi L, et al. Determinants and consequences of obesity. Am J Public Health . 2016. doi:10.2105/AJPH.2016.303326
3. Pi-Sunyer X. The medical risks of obesity. Postgrad Med . 2009. doi:10.3810/pgm.2009.11.2074
4. Chan RSM, Woo J. Prevention of overweight and obesity: How effective is the current public health approach. Int J Environ Res Public Health . 2010. doi:10.3390/ijerph7030765
5. Garmey EG, Liu Q, Sklar CA, et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: A report from the childhood cancer survivor study. J Clin Oncol . 2008. doi:10.1200/JCO.2008.16.3527
6. Reilly JJ. Obesity during and after treatment for childhood cancer.Endocr Dev . 2009. doi:10.1159/000207609
7. Skoczen S, Surmiak M, Strojny W. Survivors of acute lymphoblastic leukemia and body mass changes. Expert Opin Drug Saf . 2010. doi:10.1517/14740330903410213
8. Karaman S, Ercan O, Yildiz I, et al. Late effects of childhood ALL treatment on body mass index and serum leptin levels. J Pediatr Endocrinol Metab . 2010. doi:10.1515/JPEM.2010.23.7.669
9. Trimis G, Moschovi M, Papassotiriou I, Chrousos G, Tzortzatou-Stathopoulou F. Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. J Pediatr Hematol Oncol . 2007. doi:10.1097/MPH.0b013e318059c249
10. van Waas M, Neggers SJCMM, Pieters R, van den Heuvel-Eibrink MM. Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer. Ann Oncol . 2009. doi:10.1093/annonc/mdp414
11. Geenen MM, Bakker PJM, Kremer LCM, Kastelein JJP, Leeuwen FEV. Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy. Pediatr Blood Cancer . 2010. doi:10.1002/pbc.22518
12. Zhang FF, Parsons SK. Obesity in Childhood Cancer Survivors: Call for Early Weight Management. Adv Nutr . 2015. doi:10.3945/an.115.008946
13. Copelan E. Hematopoietic Stem-Cell Transplantation. N Engl J Med . 2006;354(17):1813-1826.
14. Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT. Blood . 2005. doi:10.1182/blood-2005-05-2004
15. Fleming DR, Rayens MK, Garrison J. Impact of obesity on allogeneic stem cell transplant patients: A matched case-controlled study. In:American Journal of Medicine . ; 1997. doi:10.1016/S0002-9343(96)00450-0
16. White M, Murphy AJ, Hallahan A, Ware RS, Fraser C, Davies PSW. Survival in overweight and underweight children undergoing hematopoietic stem cell transplantation. Eur J Clin Nutr . 2012. doi:10.1038/ejcn.2012.109
17. Inaba H, Yang J, Kaste SC, et al. Longitudinal changes in body mass and composition in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem-cell transplantation. J Clin Oncol . 2012. doi:10.1200/JCO.2011.40.0457
18. Ruble K, Hayat M, Stewart KJ, Chen A. Body composition after bone marrow transplantation in childhood. Oncol Nurs Forum . 2012. doi:10.1188/12.ONF.186-192
19. Child Growth Standards, WHO Anthro (version 3.1, June 2010) and macros. In: World Health Organization, 2010. pp macro calculate the indicators of the attained growth standards (length/height-for-age, weight-for-age, weight-for-length, weight-for-height, b.
20. A SAS Program for CDC Growth Charts. In: Center for Disease Control, 2009. p The purpose of this SAS program is to easily generate a dataset that contains indices of the anthropometric status of children from birth to 20 years of age based on the 2000 CDC.
21. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii. 1–253.
22. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA - J Am Med Assoc . 2014. doi:10.1001/jama.2014.732
23. Los Angeles County Department of Public Health. Obesity and Related Mortality in Los Angeles County: A Cities and Communities Health Report .; 2011.
24. Cohen A, Duell T, Socié G, et al. Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT late-effects working party retrospective data. Bone Marrow Transplant . 1999. doi:10.1038/sj.bmt.1701769
25. Flowers MED, Martin PJ. How we treat chronic graft-versus-host disease. Blood . 2015. doi:10.1182/blood-2014-08-551994
26. Jim HSL, Evans B, Jeong JM, et al. Sleep disruption in hematopoietic cell transplantation recipients: Prevalence, severity, and clinical management. Biol Blood Marrow Transplant . 2014. doi:10.1016/j.bbmt.2014.04.010
27. McBride B, Fiese B, Dev DA, et al. Risk factors for overweight/obesity in preschool children: An ecological approach.Child Obes . 2013. doi:10.1089/chi.2012.0150
28. Hjermstad MJ, Knobel H, Brinch L, et al. A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation. Bone Marrow Transplant . 2004. doi:10.1038/sj.bmt.1704561
29. Skaarud KJ, Veierød MB, Lergenmuller S, Bye A, Iversen PO, Tjønnfjord GE. Body weight, body composition and survival after 1 year: follow-up of a nutritional intervention trial in allo-HSCT recipients.Bone Marrow Transplant . 2019. doi:10.1038/s41409-019-0638-6
30. Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm . 2010. doi:10.1155/2010/289645
31. Bubalo J, Carpenter PA, Majhail N, et al. Conditioning Chemotherapy Dose Adjustment in Obese Patients: A Review and Position Statement by the American Society for Blood and Marrow Transplantation Practice Guideline Committee. Biol Blood Marrow Transplant . 2014. doi:10.1016/j.bbmt.2014.01.019
32. Gleimer M, Li Y, Chang L, et al. Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: Clinical characteristics and outcomes. Bone Marrow Transplant . 2015. doi:10.1038/bmt.2014.280
33. Nakao M, Chihara D, Niimi A, et al. Impact of being overweight on outcomes of hematopoietic SCT: A meta-analysis. Bone Marrow Transplant . 2014. doi:10.1038/bmt.2013.128
34. Barker CC, Agovi MA, Logan B, et al. Childhood Obesity and Outcomes after Bone Marrow Transplantation for Patients with Severe Aplastic Anemia. Biol Blood Marrow Transplant . 2011. doi:10.1016/j.bbmt.2010.08.019
35. Couto-Silva AC, Trivin C, Esperou H, Michon J, Fischer A, Brauner R. Changes in height, weight and plasma leptin after bone marrow transplantation. Bone Marrow Transplant . 2000. doi:10.1038/sj.bmt.1702718
36. Shalitin S, Phillip M, Stein J, Goshen Y, Carmi D, Yaniv I. Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplant . 2006. doi:10.1038/sj.bmt.1705374
37. Couto-Silva AC, Trivin C, Esperou H, et al. Final height and gonad function after total body irradiation during childhood. Bone Marrow Transplant . 2006. doi:10.1038/sj.bmt.1705455
38. Poirier P, Martin J, Marceau P, Biron S, Marceau S. Impact of bariatric surgery on cardiac structure, function and clinical manifestations in morbid obesity. Expert Rev Cardiovasc Ther . 2004. doi:10.1586/14779072.2.2.193
39. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss.Arterioscler Thromb Vasc Biol . 2006. doi:10.1161/01.ATV.0000216787.85457.f3
40. Chatterjee K, Zhang J, Honbo N, Karliner JS. Doxorubicin cardiomyopathy. Cardiology . 2010. doi:10.1159/000265166
41. Warburg O. On the origin of cancer cells. Science (80- ) . 1956. doi:10.1126/science.123.3191.309
42. Tan-Shalaby J. Ketogenic Diets and Cancer: Emerging Evidence.Fed Pract . 2017.
43. Di Biase S, Longo VD. Fasting-induced differential stress sensitization in cancer treatment. Mol Cell Oncol . 2016;3(3):1-2. doi:10.1080/23723556.2015.1117701
44. Longo VD, Fontana L. Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol Sci . 2010. doi:10.1016/j.tips.2009.11.004
45. Adlercreutz H. Western diet and western diseases: Some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest . 1990. doi:10.1080/00365519009085798
46. Kuriki K, Tajima K. The increasing incidence of colorectal cancer and the preventive strategy in Japan. Asian Pacific J Cancer Prev . 2006.
47. Craig WJ. Health effects of vegan diets. In: American Journal of Clinical Nutrition . ; 2009. doi:10.3945/ajcn.2009.26736N
48. Schwingshackl L, Hoffmann G. Adherence to Mediterranean diet and risk of cancer: An updated systematic review and meta-analysis of observational studies. Cancer Med . 2015;4(12):1933-1947. doi:10.1002/cam4.539
49. Gray A, Dang BN, Moore TB, Clemens RA, Pressman P. A Review of Nutrition and Dietary Interventions in Oncology. SAGE Open Med .